Silexion Therapeutics Corp · NASDAQ:SLXN
Orca Capital AG reported a 6.20% stake in Silexion Therapeutics Corp (Schedule 13G)
Event Sep 11, 2025 · Filed Sep 15, 2025
Orca Capital AG reported a 6.20% stake in Silexion Therapeutics Corp, 131,250 shares, as a passive investor on Sep 11, 2025. Filed Sep 15, 2025 (Schedule 13G).
- Stake
- 6.20%
- Shares
- 131,250
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Orca Capital AG | 6.20% | 131,250 |
Source
Related
- Silexion Therapeutics Corp
- Orca Capital AG
- Silexion Therapeutics Corp shareholders
- Schedule 13G/A · Orca Capital AG · Sep 15, 2025
- Schedule 13D/A · Moringa Sponsor, LP · Sep 28, 2026
- Schedule 13D/A · Moringa Sponsor, LP · Aug 19, 2026
- Schedule 13G · Mitchell P. Kopin · Aug 18, 2026
- Schedule 13D/A · Moringa Sponsor, LP · Jun 23, 2026
- Form 4 · Shirvan Mitchell · Jun 8, 2026